Top 10 Stocks To Own Right Now

Los Angeles, CA, based Investment company Rnc Capital Management Llc buys Sempra Energy, Citigroup Inc, Walgreens Boots Alliance Inc, Carnival Corp, Philip Morris International Inc, Cisco Systems Inc, Bank of Hawaii Corp, ServiceNow Inc, Usana Health Sciences Inc, Rockwell Automation Inc, sells Pfizer Inc, SunTrust Banks Inc, Johnson Controls International PLC, BlackRock Inc, United Technologies Corp during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Rnc Capital Management Llc. As of 2018-06-30, Rnc Capital Management Llc owns 134 stocks with a total value of $1.4 billion. These are the details of the buys and sells.

New Purchases: BOH, NOW, CAE, ROK, USNA, APTV, Added Positions: SRE, C, WBA, CCL, PM, CSCO, SLB, VZ, OMC, RDS.A, Reduced Positions: PFE, STI, BLK, UTX, XOM, BTI, LOW, GOOGL, TSN, NFX, Sold Out: JCI, AJG, EIX, MDLZ, KO, ITW, IFF, HE, FFIV, FDX,

For the details of RNC CAPITAL MANAGEMENT LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=RNC+CAPITAL+MANAGEMENT+LLC

Top 10 Stocks To Own Right Now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.815 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Westell Technologies, Inc. (NASDAQ: WSTL) was down, falling around 19 percent to $2.81 after reporting a fourth-quarter earnings miss.

    Commodities

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Recro Pharma, Inc. (NASDAQ: REPH) fell 50.3 percent to $6.17 in pre-market trading after the company received a Complete Response Letter from the FDA. The FDA declined to approve the company’s New Drug Application for IV meloxicam.
    Westell Technologies, Inc. (NASDAQ: WSTL) shares fell 16.5 percent to $2.89 in pre-market trading after the company announced Q4 results.
    Melinta Therapeutics, Inc. (NASDAQ: MLNT) fell 16.5 percent to $5.20 in pre-market trading after reporting pricing of public offering of common stock.
    Westmoreland Resource Partners, LP (NYSE: WMLP) fell 11 percent to $3.49 in pre-market trading after surging 194.03 percent on Wednesday.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) shares fell 11 percent to $13.45 in pre-market trading. Petrobras announced plans to lower the cost of diesel by 10 percent.
    Sanderson Farms, Inc. (NASDAQ: SAFM) shares fell 9.4 percent to $97 in pre-market trading after the company reported weaker-than-expected results for its second quarter.
    Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.9 percent to $15.55 in pre-market trading after rising 2.71 percent on Wednesday.
    L Brands, Inc. (NYSE: LB) shares fell 6.7 percent to $31.76 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company issued weak second quarter and FY18 earnings guidance.
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares fell 5.9 percent to $4.78 in pre-market trading.
    Qiwi plc (NASDAQ: QIWI) fell 5.9 percent to $17.52 in pre-market trading.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) fell 5 percent to $13.25 in pre-market trading after reporting a proposed offering of common stock.
    Best Buy Co Inc (NYSE: BBY) shares fell 4.3 percent to $72.66 in pre-market trading. Best Buy reported better-than-expected earnings for its first quarter.
    NetApp Inc. (NASDAQ: NTAP) fell 4.1 percent to $64.

Top 10 Stocks To Own Right Now: Equity Residential(EQR)

Advisors’ Opinion:

  • [By Logan Wallace]

    DiamondRock Hospitality (NYSE:DRH) and Equity Residential (NYSE:EQR) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Equity Residential (NYSE:EQR) by 0.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,723 shares of the real estate investment trust’s stock after buying an additional 827 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned approximately 0.05% of Equity Residential worth $12,122,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Equity Residential (EQR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Equity Residential (NYSE:EQR) Vice Chairman Gerald A. Spector sold 13,024 shares of the business’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $67.50, for a total transaction of $879,120.00. Following the completion of the sale, the insider now owns 294,287 shares in the company, valued at $19,864,372.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Ethan Ryder]

    Oppenheimer Asset Management Inc. decreased its position in shares of Equity Residential (NYSE:EQR) by 23.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 25,650 shares of the real estate investment trust’s stock after selling 7,654 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Equity Residential were worth $1,580,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Ethan Ryder]

    Equity Residential (NYSE:EQR) had its target price lowered by Morgan Stanley from $66.50 to $63.00 in a report released on Thursday. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Morgan Stanley’s target price points to a potential downside of 0.76% from the stock’s previous close.

Top 10 Stocks To Own Right Now: Blue Capital Reinsurance Holdings Ltd.(BCRH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RLI (NYSE: BCRH) and Blue Capital Reinsurance (NYSE:BCRH) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Max Byerly]

    News articles about Blue Capital Reinsurance (NYSE:BCRH) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blue Capital Reinsurance earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the insurance provider an impact score of 47.9769004082468 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Akari Therapeutics alerts:

    Akari Therapeutics, Plc (AKTX) Analysts See $-1.00 EPS; HC INTERNATIONAL ORDINARY SHARES CA (HCINF … (mtastar.com) Trader’s Buzzers- Boxlight Corporation (NASDAQ:BOXL), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH), Akari … (journalfinance.net) Akari Therapeutics (AKTX) Lifted to “Hold” at ValuEngine (americanbankingnews.com) Guillain-Barre Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMRGlobal Guillain–Barre Syndrome … (markets.businessinsider.com) Analysts See $-1.00 EPS for Akari Therapeutics, Plc (AKTX); Verastem (VSTM) SI Decreased By 7.78% (mtastar.com)

    Several brokerages have commented on AKTX. ValuEngine upgraded Akari Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity cut their target price on Akari Therapeutics from $15.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, March 29th. B. Riley began coverage on Akari Therapeutics in a research note on Thursday, February 8th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Zacks Investment Research downgraded Akari Therapeutics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $4.63.

  • [By Shane Hupp]

    Blue Capital Reinsurance (NYSE:BCRH) reached a new 52-week high and low during trading on Thursday . The company traded as low as $10.90 and last traded at $11.05, with a volume of 17133 shares trading hands. The stock had previously closed at $11.20.

Top 10 Stocks To Own Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    KBR, Inc. (NYSE:KBR) announced a quarterly dividend on Friday, August 10th, Wall Street Journal reports. Investors of record on Monday, September 17th will be given a dividend of 0.08 per share by the construction company on Monday, October 15th. This represents a $0.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Friday, September 14th.

  • [By ]

    KBR (NYSE: KBR)
    Though an under-the-radar name, KBR was the construction arm of oilfield services giant Halliburton (NYSE: HAL) before being spun off. With a consolidated market cap of $2.6 billion, KBR describes itself, per its website, as a “global provider of differentiated professional services and technologies… within the Government Services and Hydrocarbon sectors.”

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own Right Now: Big 5 Sporting Goods Corporation(BGFV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Big 5 Sporting Goods alerts:

    Why Big 5 Sporting Goods Corporation (BGFV) Could Shock the Market Soon (zacks.com) Big 5 Sporting Goods (BGFV) Cut to Sell at ValuEngine (americanbankingnews.com) It’s Time To Sell Big 5 Sporting Goods (seekingalpha.com) Big 5 Sporting Goods Corp Stock [FallsFell] as Big Money Exit, Sentiment at 0.82 (thecasualsmart.com) A Look at Some Alternative Metrics For Big 5 Sporting Goods Corporation (NasdaqGS:BGFV) (derbynewsjournal.com)

    Several analysts have weighed in on BGFV shares. Zacks Investment Research raised shares of Big 5 Sporting Goods from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 13th. ValuEngine raised shares of Big 5 Sporting Goods from a “sell” rating to a “hold” rating in a research report on Wednesday, March 7th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $9.08.

  • [By ]

    Yet, while imperfect, this little figure can help pinpoint underpriced stocks that have room to climb, especially when book value is rising. That just might be the case with sporting goods retailer Big Five (Nasdaq: BGFV). The company operates 435 stores in 11 states, selling everything from camping gear to snow skis.

  • [By Max Byerly]

    Press coverage about Big 5 Sporting Goods (NASDAQ:BGFV) has trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Big 5 Sporting Goods earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 48.2140595662163 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Citigroup Inc. lifted its holdings in shares of Big 5 Sporting Goods Co. (NASDAQ:BGFV) by 5,069.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,559 shares of the company’s stock after buying an additional 15,258 shares during the period. Citigroup Inc. owned about 0.07% of Big 5 Sporting Goods worth $112,000 at the end of the most recent quarter.

Top 10 Stocks To Own Right Now: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Max Byerly]

    Williams-Sonoma (NYSE:WSM) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $4.26-4.36 for the period, compared to the Thomson Reuters consensus estimate of $4.24. The company issued revenue guidance of $5.57-5.67 billion, compared to the consensus revenue estimate of $5.62 billion.Williams-Sonoma also updated its Q3 guidance to $0.90-0.95 EPS.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Lisa Levin]

    Breaking news

    Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected earnings for its first quarter.
    Sanderson Farms, Inc. (NASDAQ: SAFM) reported weaker-than-expected results for its second quarter.
    Medtronic plc (NYSE: MDT) reported upbeat earnings for its fourth quarter on Thursday.
    Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Top 10 Stocks To Own Right Now: Basilea Pharmaceutica Ltd. (BPMUF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Basilea Pharmaceutica (BPMUF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Basilea Pharmaceuticals (OTC:BPMUF)

    BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called “tumor checkpoint controller” inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.

Top 10 Stocks To Own Right Now: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Max Byerly]

    Marathon Patent Group (NASDAQ: MARA) and Finjan (NASDAQ:FNJN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

  • [By Max Byerly]

    Finjan Holdings Inc (NASDAQ:FNJN) shares saw an uptick in trading volume on Tuesday . 32,387 shares changed hands during trading, a decline of 93% from the previous session’s volume of 494,407 shares.The stock last traded at $4.98 and had previously closed at $5.08.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    ValuEngine upgraded shares of Finjan (NASDAQ:FNJN) from a hold rating to a buy rating in a research report sent to investors on Monday.

    Separately, TheStreet upgraded Finjan from a c+ rating to a b- rating in a research report on Tuesday, August 14th.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:

    Get Finjan alerts:

    You Need To Taste These: Finjan Holdings, Inc. (NASDAQ:FNJN), The Dixie Group, Inc. (NASDAQ:DXYN), Sky Solar … (thestreetpoint.com) With a 125/250 Day Adjusted Slope of 63.35003, Is Finjan Holdings, Inc. (NasdaqCM:FNJN) a Favorable Pick? (cantoncaller.com) Which Option is Best? Finjan Holdings, Inc. (FNJN) Buy or Sell (topdesertsafari.com) Finjan Holdings Inc (FNJN) Given Average Recommendation of “Strong Buy” by Analysts (americanbankingnews.com)

    Several research analysts recently issued reports on the stock. TheStreet raised shares of Finjan from a “c+” rating to a “b-” rating in a report on Tuesday, August 14th. Dawson James reissued a “buy” rating on shares of Finjan in a report on Tuesday, May 22nd. Finally, ValuEngine cut shares of Finjan from a “buy” rating to a “hold” rating in a report on Thursday, August 2nd.

Top 10 Stocks To Own Right Now: Israel Chemicals Shs(ICL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Itasca Capital Ltd (CVE:ICL) Director Richard Michael Powell bought 25,000 shares of the company’s stock in a transaction on Monday, August 13th. The shares were bought at an average cost of C$0.57 per share, for a total transaction of C$14,250.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Israel Chemicals (NYSE: ICL) and Evogene (NASDAQ:EVGN) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Joseph Griffin]

    Israel Chemicals (NYSE:ICL) – Equities researchers at Jefferies Group issued their Q2 2018 earnings per share estimates for shares of Israel Chemicals in a research note issued on Monday, May 14th. Jefferies Group analyst L. Alexander forecasts that the basic materials company will post earnings of $0.09 per share for the quarter. Jefferies Group also issued estimates for Israel Chemicals’ Q3 2018 earnings at $0.11 EPS and Q4 2018 earnings at $0.10 EPS.

  • [By Stephan Byrd]

    Israel Chemicals (NYSE:ICL) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Kingstone Companies (NASDAQ:KINS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Top 10 Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ascent Capital Group Inc Series A (ASCMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

  • [By Shane Hupp]

    News stories about Ascent Capital Group Inc Series A (NASDAQ:ASCMA) have trended somewhat negative on Wednesday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ascent Capital Group Inc Series A earned a news sentiment score of -0.02 on Accern’s scale. Accern also assigned news coverage about the industrial products company an impact score of 46.5362897974896 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Leave a Reply

Your email address will not be published. Required fields are marked *